XML 42 R3.htm IDEA: XBRL DOCUMENT v3.23.1
CONSOLIDATED STATEMENTS OF PROFIT OR LOSS AND OTHER COMPREHENSIVE LOSS - USD ($)
$ in Thousands
 12 Months Ended
Dec. 31, 2022
Dec. 31, 2021
Dec. 31, 2020
CONSOLIDATED STATEMENTS OF PROFIT OR LOSS AND OTHER COMPREHENSIVE LOSS      
Revenue $ 19,085 $ 11,117 $ 8,509
Cost of revenue 7,859 4,596 4,273
Gross profit 11,226 6,521 4,236
Operating expenses:      
Research and development 10,217 7,822 6,910
Selling and marketing 12,749 8,774 5,807
General and administrative 9,645 6,273 4,562
Reorganization     891
Transaction-related costs 2,887    
Total operating expenses 35,498 22,869 18,170
Operating loss (24,272) (16,348) (13,934)
Finance income 194 150 193
Finance expenses (454) (156) (172)
Financing income (expenses), net (260) (6) 21
Loss before income taxes (24,532) (16,354) (13,913)
Income taxes 169 4 259
Loss (24,701) (16,358) (14,172)
Other comprehensive loss (net of tax effect):      
Remeasurement profit (loss) from defined benefit plans 269 (81) (51)
Total components that will not be reclassified subsequently to profit or loss 269 (81) (51)
Total comprehensive loss $ (24,432) $ (16,439) $ (14,223)
Basic loss per Ordinary share $ 4.25 $ (3.94) $ (3.48)
Diluted loss per Ordinary share   $ (3.94) $ (3.48)
Weighted average number of shares outstanding used to compute basic loss per share 7,930,928 6,242,946 5,945,888
Weighted average number of shares outstanding used to compute diluted loss per share 7,930,928 6,242,946 5,945,888